Wockhardt

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE049B01025
NSEID: WOCKPHARMA
BSEID: 532300

INR

1,360.00

28.1 (2.11%)

BSENSE

Dec 05

BSE+NSE Vol: 55.51 lacs

{
  "main_header": {
    "sid": 256229,
    "name": "Wockhardt",
    "stock_name": "Wockhardt",
    "full_name": "Wockhardt Ltd",
    "name_url": "stocks-analysis/wockhardt",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,360.00",
    "chg": 28.1,
    "chgp": "2.11%",
    "dir": 1,
    "prev_price": "1,331.90",
    "mcapval": "22,521.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532300,
    "symbol": "WOCKPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE049B01025",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "55.51 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/wockhardt-256229-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Wockhardt Sees Elevated Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-high-value-trading-amid-sector-outperformance-and-institutional-interest-3748430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3748430.png",
        "date": "2025-12-05 10:00:07",
        "description": "Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, recorded significant trading volumes and value turnover on 5 December 2025, reflecting heightened market interest. The stock outperformed its sector peers and demonstrated a notable intraday price movement, signalling renewed investor focus amid a fluctuating market environment."
      },
      {
        "title": "Is Wockhardt overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wockhardt-overvalued-or-undervalued-3745150",
        "imagepath": "",
        "date": "2025-12-04 08:11:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Examining Wockhardt’s Valuation Metrics</strong></p>\n<p>Wockhardt’s price-to-earnings (PE) ratio stands at an extraordinary 310.7, far exceeding typical industry standards and signalling a premium valuation. This figure dwarfs the PE ratios of many peers, including Sun Pharma Industries and Divi’s Laboratories, which themselves are considered expensive or very expensive. The company’s price-to-book value of 5.04 also suggests investors are paying a significant premium over its net asset value.</p>\n<p>Enterprise value multiples further highlight the stretched valuation. The EV to EBIT ratio is 108.98, and EV to EBITDA is 55.48, both substantially higher than industry averages. These elevated multiples imply that the market expects robust future earnings growth or unique competitive advantages..."
      },
      {
        "title": "Why is Wockhardt falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-wockhardt-fallingrising-3744850",
        "imagepath": "",
        "date": "2025-12-04 00:28:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Price Movement and Market Sentiment</strong></p>\n<p>Wockhardt’s shares touched an intraday low of ₹1,405.05, down nearly 6% from previous levels, signalling significant selling pressure. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting that sellers dominated the session. This decline came despite the stock outperforming the Sensex over the past week by a substantial margin, with a 10.67% gain compared to the benchmark’s 0.59% loss. However, the stock’s year-to-date performance remains slightly negative at -0.30%, underperforming the Sensex’s 8.92% rise.</p>\n<p>Technical indicators show the stock trading above its 5-day, 20-day, and 50-day moving averages, but below the 100-day and 200-day averages. This mixed technical pi..."
      },
      {
        "title": "Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-heavy-value-trading-and-institutional-interest-amid-sector-outperformance-3741225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3741225.png",
        "date": "2025-12-02 10:00:09",
        "description": "Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 2 December 2025. The stock demonstrated notable trading volumes and value turnover, outperforming its sector peers and reflecting heightened investor interest and liquidity in the market."
      },
      {
        "title": "Is Wockhardt technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wockhardt-technically-bullish-or-bearish-3739991",
        "imagepath": "",
        "date": "2025-12-02 08:24:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Recent Price Movements</strong></p>\n<p>Wockhardt’s current market price stands at ₹1,470.90, having surged from a previous close of ₹1,233.55. The stock’s intraday range on the latest trading session was between ₹1,226.15 and ₹1,480.25, indicating notable volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹1,109.60 and a high of ₹1,870.00, reflecting a broad trading band that investors should consider when evaluating risk and reward.</p>\n<p><strong>Technical Trend Shift: From Bearish to Mildly Bearish</strong></p>\n<p>As of 1 December 2025, Wockhardt’s overall technical trend has transitioned from bearish to mildly bearish. This subtle shift suggests that while the stock remains under some selling pressure, the intensity of bearish momentum has eas..."
      },
      {
        "title": "Wockhardt Stock Analysis: Technical Momentum and Market Assessment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-shares-surge-amid-mixed-technical-signals-and-momentum-shift-3739925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_technicaldot_3739925.png",
        "date": "2025-12-02 08:02:47",
        "description": "Wockhardt’s recent trading activity reveals a notable shift in technical momentum, with key indicators signalling a transition from a bearish stance to a more nuanced mildly bearish outlook. The stock’s price movement, combined with mixed signals from MACD, RSI, and moving averages, offers investors a complex picture amid a volatile market backdrop."
      },
      {
        "title": "How has been the historical performance of Wockhardt?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-wockhardt-3739168",
        "imagepath": "",
        "date": "2025-12-01 23:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Operating Performance Trends</strong></p>\n<p>Wockhardt's net sales have experienced variability, with figures peaking at ₹3,565 crore in March 2019 before declining and fluctuating in subsequent years. The fiscal year ending March 2025 recorded net sales of ₹3,012 crore, reflecting a modest recovery from the previous year’s ₹2,798 crore. This oscillation in revenue highlights the competitive pressures and market dynamics faced by the pharmaceutical company.</p>\n<p>Operating profit margins excluding other income have shown a gradual improvement, reaching 13.05% in March 2025 compared to a low of 1.39% in the prior year. The operating profit (PBDIT) excluding other income rose significantly to ₹393 crore in the latest fiscal year from ₹39 crore in March 2024, signalling enhanced op..."
      },
      {
        "title": "Wockhardt Sees High-Value Trading Amidst Volatile Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-surges-on-heavy-value-trading-amid-institutional-interest-3738715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_most_active_equities_by_value_3738715.png",
        "date": "2025-12-01 13:00:08",
        "description": "Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 1 December 2025. The stock demonstrated significant price movement and trading volume, reflecting heightened investor interest and notable liquidity in a volatile market environment."
      },
      {
        "title": "Wockhardt Hits Day High with Strong Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-hits-day-high-with-765-intraday-surge-on-1-dec-2025-3738661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Wockhardt_priceRelatedfactors_3738661.png",
        "date": "2025-12-01 11:46:38",
        "description": "Wockhardt recorded a notable intraday rally on 1 December 2025, reaching its highest price point of the day amid a broader positive market environment. The pharmaceutical company’s shares outpaced sector and benchmark indices, reflecting a significant shift in trading momentum after a brief period of decline."
      }
    ],
    "total": 377,
    "sid": "256229",
    "stock_news_url": "https://www.marketsmojo.com/news/wockhardt-256229"
  },
  "announcements": [
    {
      "details": "Wockhardt Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI ( LODR) Regulations, 2015. (SEBI Listing Regulations)",
      "source": "NSE",
      "caption": "Wockhardt Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Wockhardt Limited has informed the Exchange regarding 'extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2019 published in the newspaper in relation to Results got approved in the Board Meeting held on 7th November, 2019'.",
      "source": "NSE",
      "caption": "Wockhardt Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Wockhardt Limited has informed the Exchange regarding Grant of 76000 Options.",
      "source": "NSE",
      "caption": "Wockhardt Limited - ESOP/ESOS/ESPS",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 16",
          "dt": "2016-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has announced <strong>3:10</strong> rights issue, ex-date: 08 Mar 22",
          "dt": "2022-03-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Wockhardt Sees Elevated Trading Activity Amidst Sector Outperformance

2025-12-05 10:00:07

Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, recorded significant trading volumes and value turnover on 5 December 2025, reflecting heightened market interest. The stock outperformed its sector peers and demonstrated a notable intraday price movement, signalling renewed investor focus amid a fluctuating market environment.

Is Wockhardt overvalued or undervalued?

2025-12-04 08:11:24

Examining Wockhardt’s Valuation Metrics

Wockhardt’s price-to-earnings (PE) ratio stands at an extraordinary 310.7, far exceeding typical industry standards and signalling a premium valuation. This figure dwarfs the PE ratios of many peers, including Sun Pharma Industries and Divi’s Laboratories, which themselves are considered expensive or very expensive. The company’s price-to-book value of 5.04 also suggests investors are paying a significant premium over its net asset value.

Enterprise value multiples further highlight the stretched valuation. The EV to EBIT ratio is 108.98, and EV to EBITDA is 55.48, both substantially higher than industry averages. These elevated multiples imply that the market expects robust future earnings growth or unique competitive advantages...

Why is Wockhardt falling/rising?

2025-12-04 00:28:26

Intraday Price Movement and Market Sentiment

Wockhardt’s shares touched an intraday low of ₹1,405.05, down nearly 6% from previous levels, signalling significant selling pressure. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting that sellers dominated the session. This decline came despite the stock outperforming the Sensex over the past week by a substantial margin, with a 10.67% gain compared to the benchmark’s 0.59% loss. However, the stock’s year-to-date performance remains slightly negative at -0.30%, underperforming the Sensex’s 8.92% rise.

Technical indicators show the stock trading above its 5-day, 20-day, and 50-day moving averages, but below the 100-day and 200-day averages. This mixed technical pi...

Wockhardt Sees Robust Trading Activity Amidst Sector Outperformance

2025-12-02 10:00:09

Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 2 December 2025. The stock demonstrated notable trading volumes and value turnover, outperforming its sector peers and reflecting heightened investor interest and liquidity in the market.

Is Wockhardt technically bullish or bearish?

2025-12-02 08:24:29

Overview of Recent Price Movements

Wockhardt’s current market price stands at ₹1,470.90, having surged from a previous close of ₹1,233.55. The stock’s intraday range on the latest trading session was between ₹1,226.15 and ₹1,480.25, indicating notable volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹1,109.60 and a high of ₹1,870.00, reflecting a broad trading band that investors should consider when evaluating risk and reward.

Technical Trend Shift: From Bearish to Mildly Bearish

As of 1 December 2025, Wockhardt’s overall technical trend has transitioned from bearish to mildly bearish. This subtle shift suggests that while the stock remains under some selling pressure, the intensity of bearish momentum has eas...

Wockhardt Stock Analysis: Technical Momentum and Market Assessment

2025-12-02 08:02:47

Wockhardt’s recent trading activity reveals a notable shift in technical momentum, with key indicators signalling a transition from a bearish stance to a more nuanced mildly bearish outlook. The stock’s price movement, combined with mixed signals from MACD, RSI, and moving averages, offers investors a complex picture amid a volatile market backdrop.

How has been the historical performance of Wockhardt?

2025-12-01 23:00:55

Revenue and Operating Performance Trends

Wockhardt's net sales have experienced variability, with figures peaking at ₹3,565 crore in March 2019 before declining and fluctuating in subsequent years. The fiscal year ending March 2025 recorded net sales of ₹3,012 crore, reflecting a modest recovery from the previous year’s ₹2,798 crore. This oscillation in revenue highlights the competitive pressures and market dynamics faced by the pharmaceutical company.

Operating profit margins excluding other income have shown a gradual improvement, reaching 13.05% in March 2025 compared to a low of 1.39% in the prior year. The operating profit (PBDIT) excluding other income rose significantly to ₹393 crore in the latest fiscal year from ₹39 crore in March 2024, signalling enhanced op...

Wockhardt Sees High-Value Trading Amidst Volatile Market Activity

2025-12-01 13:00:08

Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 1 December 2025. The stock demonstrated significant price movement and trading volume, reflecting heightened investor interest and notable liquidity in a volatile market environment.

Wockhardt Hits Day High with Strong Intraday Surge

2025-12-01 11:46:38

Wockhardt recorded a notable intraday rally on 1 December 2025, reaching its highest price point of the day amid a broader positive market environment. The pharmaceutical company’s shares outpaced sector and benchmark indices, reflecting a significant shift in trading momentum after a brief period of decline.

View All News

Announcement

Wockhardt Limited - Other General Purpose

03-Dec-2019 | Source : NSE

Wockhardt Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI ( LODR) Regulations, 2015. (SEBI Listing Regulations)

Wockhardt Limited - Updates

13-Nov-2019 | Source : NSE

Wockhardt Limited has informed the Exchange regarding 'extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2019 published in the newspaper in relation to Results got approved in the Board Meeting held on 7th November, 2019'.